Sartorius Stedim Biotech S.A. logo

Sartorius Stedim Biotech S.A. (56S1)

Market Open
12 Jun, 20:00
176. 10
-0.9
-0.5085%
- Market Cap
- P/E Ratio
0.49% Div Yield
0 Volume
- Eps
177
Previous Close
Add Transaction
Day Range
176.1 180
Year Range
150 222.3
Want to track 56S1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

56S1 trading today lower at €176.1, a decrease of -0.5085% from yesterday's close, completing a monthly decrease of -1.2339% or -€2.2. Over the past 12 months, 56S1 stock lost -16.0629%.
56S1 pays dividends to its shareholders, with the most recent payment made on Apr 02, 2026. The next estimated payment will be in 2 months ago on Apr 02, 2026 for a total of €0.69.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -1.21%. On average, the company has fell short of earnings expectations by -1.165%, based on the last three reports.
Sartorius Stedim Biotech S.A. has completed 8 stock splits, with the recent split occurring on May 06, 2016.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on XPAR (EUR).

56S1 Chart

Sartorius Stedim Biotech S.A. (56S1) FAQ

What is the stock price today?

The current price is €176.10.

On which exchange is it traded?

Sartorius Stedim Biotech S.A. is listed on XHAN.

What is its stock symbol?

The ticker symbol is 56S1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.49%.

What is its market cap?

As of today, no market cap data is available.

Has Sartorius Stedim Biotech S.A. ever had a stock split?

Sartorius Stedim Biotech S.A. had 8 splits and the recent split was on May 06, 2016.

Sartorius Stedim Biotech S.A. Profile

Textiles, Apparel & Luxury Goods Industry
Consumer Discretionary Sector
Rene Faber CEO
XHAN Exchange
FR0013154002 ISIN
FR Country
9,961 Employees
31 Mar 2026 Last Dividend
16 Jun 2005 Last Split
- IPO Date

Overview

Sartorius Stedim Biotech S.A. is a cornerstone in the biopharmaceutical industry, providing a vast array of instruments and consumables used globally. The company's extensive product portfolio caters to the needs of medication manufacturers, food industries, chemical sectors, as well as research and development laboratories. Founded in 1870, with its headquarters in Aubagne, France, it stands as a subsidiary of Sartorius AG. Its offerings facilitate numerous critical processes in the biopharmaceutical production and development chain, from cell cultivation to the transportation of biological products.

Products and Services

  • Cell Lines & Cell Culture Media: These foundational components are essential for the cultivation and maintenance of cells in the laboratory, enabling the growth of precise and replicable biological products.
  • Bioreactors: Sartorius Stedim Biotech S.A. provides cutting-edge bioreactors that are integral for the cell cultivation process, facilitating the development of vaccines, enzymes, and other biotherapeutic agents.
  • Separation, Purification, and Concentration Products: A comprehensive range of products designed for the critical stages of biopharmaceutical manufacturing, ensuring the purity and potency of the final products.
  • Storage and Transportation Systems: Solutions for the safe handling, storage, and transportation of intermediate and finished biological products, addressing the challenges of maintaining product integrity.
  • Service Offerings: The company extends its expertise through services in cell cultivation, fermentation, separation, purification, and fluid management, further supporting the biopharmaceutical production cycle.
  • Batch and Intensified Chromatography Systems: These systems are tailored for smaller molecules, like oligonucleotides, peptides, and insulin, optimizing purification processes for efficiency and effectiveness.
  • Recombinant Albumin-Based Solutions: Offering a safe and animal-free alternative for cell culture growth mediums, enhancing the productivity and reliability of biopharmaceutical products.
  • Data Analytics Software: Advanced software solutions for modeling and optimizing the processes of biopharmaceutical development and production, empowering companies with data-driven insights for process improvement.

Contact Information

Address: Zone Industrielle Les Paluds
Phone: 33 4 42 84 56 00